Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | CRHBP | P24387 | 2/20 | 0.37 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | DRD4 | P21917 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28482465 | 0.83 | TDP1 (0.56) | MAOBGRM5CA12CA2CA9 | |
| SCHEMBL6553719 | 0.80 | MAOB (0.34) | MAOBGRM5 | |
| SCHEMBL6675221 | 0.80 | GLA (0.47) | MAOBGRM5MEN1KMT2AMAPT | |
| SCHEMBL9174261 | 0.78 | CYP2A6 (0.43) | CA12CA2CA9KMT2AALDH1A1 | |
| SCHEMBL149631 | 0.78 | ALDH1A1 (0.49) | CA12CA2CA9MEN1KMT2A | |
| SCHEMBL5148459 | 0.78 | APP (0.39) | MAOBHTTTAAR1MAPTAOC3 | |
| SCHEMBL6671505 | 0.78 | PYCR1 (0.39) | MAOBMEN1KMT2ATAAR1MAPT | |
| SCHEMBL6929485 | 0.77 | CA12 (0.47) | MAOBGRM5CA12CA2CA9 | |
| SCHEMBL5982497 | 0.77 | MAOB (0.53) | MAOBGRM5CA12CA2CA9 | |
| SCHEMBL8331122 | 0.77 | GRM5 (0.53) | MAOBGRM5CA12CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114195640-B | Synthesis process of hydroxytyrosol and intermediate thereof | 攀枝花学院 | 2024-03-12 | — | — | CN | disclosed |
| US-20230303568-A1 | INTERMEDIATE USEFUL FOR THE SYNTHESIS OF TGF-BETA INHIBITORS AND A METHOD OF PREPARING TGF-BETA INHIBITORS USING THE SAME | MEDPACTO INC. (KR) | 2023-09-28 | — | — | US | disclosed |
| CN-113264881-B | Synthetic method of alpha-cyanide | 南昌大学 | 2022-12-02 | — | — | CN | disclosed |
| CN-113264881-A | Synthetic method of alpha-cyanide | 南昌大学 | 2021-08-17 | — | — | CN | disclosed |
| US-10689504-B2 | Two part curable composition | Henkel IP & Holding GmbH (DE) | 2020-06-23 | — | — | US | disclosed |
| US-20190023872-A1 | TWO PART CURABLE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2019-01-24 | — | — | US | disclosed |
| US-9969690-B2 | Cure accelerators for anaerobic curable compositions | Henkel IP & Holding GmbH (DE) | 2018-05-15 | — | — | US | disclosed |
| US-9969690-B2 | Cure accelerators for anaerobic curable compositions | Henkel IP & Holding GmbH (DE) | 2018-05-15 | — | — | US | disclosed |
| WO-2017172270-A1 | TWO PART CURABLE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2017-10-05 | — | — | WO | disclosed |
| US-20170174630-A1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2017-06-22 | — | — | US | disclosed |
| EP-1174419-A1 | A method for producing an alpha-aminonitrile from a tertiary amine and a cyanide through oxidation with oxygen by using a transition metal catalyst | OSAKA UNIVERSITY (JP) | 2002-01-23 | — | — | EP | disclosed |
| EP-0803083-B1 | IMAGE-RECORDING MATERIALS | POLAROID CORP (US) | 1999-04-21 | — | — | EP | disclosed |
| EP-0664999-B1 | Use of heat curable compositions as dental material | IVOCLAR AG (LI) | 1999-03-24 | — | — | EP | disclosed |
| EP-0803083-A1 | IMAGE-RECORDING MATERIALS | POLAROID CORPORATION (US) | 1997-10-29 | — | — | EP | disclosed |
| US-5674986-A | FOR HEAT-DEVELOPABLE PHOTOSENSITIVE IMAGE-RECORDING MATERIALS | POLAROID CORPORATION (US) | 1997-10-07 | — | — | US | disclosed |
| WO-1997018497-A1 | IMAGE-RECORDING MATERIALS | POLAROID CORPORATION (US) | 1997-05-22 | — | — | WO | disclosed |
| US-5569574-A | CONTAINING CYCLIC 1,3-SULFUR-OXYGEN MOIETY; DIFFUSION TRANSFER PROCESSES | POLAROID CORPORATION (US) | 1996-10-29 | — | — | US | disclosed |
| US-5539017-A | BETA-DICARBONYL COMPOUNDS AND ALPHA,BETA-UNSATURATED ESTERS OF CARBOXYLIC ACIDS | IVOCLAR AG (LI) | 1996-07-23 | — | — | US | disclosed |
| EP-0664999-A1 | Use of heat curable compositions as dental material | IVOCLAR AG (LI) | 1995-08-02 | — | — | EP | disclosed |
| US-4159192-A | CYANO-METHINE DYES | CIBA-GEIGY AG (CH) | 1979-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174630-A1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | AHCY, AHCYL1, CAPG | MAOB 3041/4885GRM5 1368/4885CA12 1642/4885 |
| US-20230303568-A1 | INTERMEDIATE USEFUL FOR THE SYNTHESIS OF TGF-BETA INHIBITORS AND A METHOD OF PREPARING TGF-BETA INHIBITORS USING THE SAME | TGFB1, TGFBR1, TGFB2 | MAOB 1076/4885GRM5 4288/4885CA12 3524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.